The MANTA vascular closure device (Essential Medical, Inc., Exton, Pennsylvania) had a successful US investigational device exemption (IDE) study with low major and minor complication rates and a short average time to hemostasis, according to results presented recently at the Transcatheter Valve Therapies (TVT) conference in Chicago.